On the other hand, AnxA1 or AnxA1-related peptides counteract non-alcoholic steatohepatitis [13], as well as atherosclerosis and cardiovascular disease triggered by hyperlipidemia [14–16]. Here, ANXA1 is linked to atherosclerosis.